Clinical Trial Update: Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating hyperbaric oxygen therapy versus placebo for vaso-occlusive crisis in sickle cell disease; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Vaso-occlusive Crisis

Drugs mentioned

• Hyperbaric Oxygen Therapy

Snippet

Sponsor: University Hospital, Geneva | Conditions: Sickle Cell Disease, Hyperbaric Oxygen Therapy | Phase 3 | Status: UNKNOWN